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"In government we treat people living with HIV/AIDS as partners… they have a very important role in educating peo-
ple and communities,helping to diminish stigma and discrimination,and giving mutual support.They are very
important in some of our decision-making.We recognize their outstanding work."
Dr SombatThanprasertsuk,
Director,Bureau of AIDS,TB and STI,Ministry of Public Health,Bangkok.
"Treatment is not only an issue for doctors.People living with HIV/AIDS should be in the driving seat."
Mr Kamon Upakaew,
Chairman,Thai Network for People Living with HIV/AIDS.
"People living with HIV/AIDS (PLHA) have a lot of information about opportunistic infections and about antiretroviral
therapy.This makes health staff more active as they have to stay ahead.It's good if PLHA can screen themselves and
help their friends:health staff need to discuss treatment with PLHA,but now they don't need to spend a lot of time
explaining basic information …These trained PLHA are good to work with.They are expert trainers of their friends,
they can plan their work and they can carry out their plans." 
Ms Porntip Kemngern,
Nurse,northern Thailand.
"If I were not HIV-positive I would still be a housewife and be working in the rice field.I would never have learnt how
to say what I want or how I feel.I would never have learnt how to discuss health problems with my doctor."
Ms Buarian,north-eastThailand.
Box 1.Comments by key stakeholders
INTRODUCTION
In 2001 the Thai Ministry of Public Health (MOPH) launched
an antiretroviral therapy (ART) programme. A decentralized
approach was adopted and treatment was initially provided to
1500 people living with HIV/AIDS (PLHA) in 112 govern-
ment hospitals (1). Previously, health care for PLHA had been
provided from specialist centres. By February 2004,
23 000 PLHA were being treated in 860 hospitals. 
In 2003 the Ministry undertook to provide 50 000 people with
ART by 2005 and it is intended that 20 000 more will receive
ART through a social insurance scheme. This amounts to close
to complete coverage and exceeds the WHO "3 by 5" target. 
In parallel with these efforts, patient groups and nongovern-
mental organizations (NGOs) have been working to provide
PLHA with enough knowledge to make informed decisions
on treatment and to play a central role as partners in the pro-
vision of care. This began in November 2000 as a nationwide
community response to inadequate access to the prevention
and treatment of opportunistic infections (OIs), and has pre-
pared the ground for PLHA to provide practical support for
the rapidly increasing access to antiretroviral drugs provided
by the government. 
The change in the role of PLHA from being passive con-
sumers of health care to becoming partners in care provision
has helped to build their confidence and pride as well as gain-
ing them greater respect from public health service staff. The
present case study outlines the work of PLHA and their NGO
partners over the last four years.
CIVIL SOCIETY AND AIDS IN THAILAND
The PLHA movement in Thailand is a movement of the rural
wives or unemployed people. PLHA groups were first estab-
lished in the early 1990s as a means of providing mutual sup-
port. There are about 600 of them, mostly hospital-based with
a nurse supervisor and receiving funding from the MOPH or
from local government. 
NGOs and PLHA groups have played a key role in Thailand's
response to HIV/AIDS since the first cases were notified over
15 years ago (2, 3). An early advocacy effort by NGOs focused
on persuading the government to abandon legislation that
would have required compulsory HIV testing. In 1998 a
coalition of local and international NGOs and PLHA groups
began to challenge the high price and monopolistic situation
of antiretroviral (ARV) drugs in Thailand (4). Action has
included the provision of legal and political support for gener-
ic drug production. A major victory was gained in 2002 when
PLHA won a court case against a multinational pharmaceuti-
cal company, overturning a patent on the ARV drug didano-
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poor, most of whom are farm or factory labourers, house-sine (5). NGOs and PLHA groups have also lobbied for uni-
versal access to ART for all PLHA who need it.
Advocacy alone is not enough. In 2000, as part of a problem-
solving approach to the inadequacy of access to treatment,
two NGOs and a network of PLHA groups began providing
education on treatment within their own communities and
cooperating with the health care system to prepare for wider
availability of treatment (Box 2). 
PROMOTING PREVENTION AND
TREATMENT OF OPPORTUNISTIC
INFECTIONS
Inadequate access to treatment is a major problem in address-
ing the HIV/AIDS epidemic throughout the developing
world. The political focus over the last few years, both inter-
nationally and in Thailand, has been on increasing access to
ART. However, the prevention and treatment of OIs is also
essential. Pneumocystis carinii pneumonia (PCP) is the second
commonest cause of death among PLHA in Thailand,
accounting for 18.4% mortality in 1999 (6). The disease is
preventable and treatable with co-trimoxazole, an inexpensive
antibiotic. The two other major OIs are tuberculosis (TB) and
cryptococcal meningitis (hereby referred to as meningitis). In
1999, TB and meningitis accounted for 26.4% and 16.9% of
deaths among PLHA respectively. The MOPH treatment
guidelines include co-trimoxazole prophylaxis for PCP, stan-
dard six-month anti-TB therapy and fluconazole secondary
prophylaxis for  meningitis (7).
While advocating for lower prices of ARV drugs, Thai PLHA
continued to see their friends dying of PCP and other pre-
ventable OIs. A decision was taken in 2000 by TNP+, MSF
and AAF to launch a campaign aimed at increasing access to
co-trimoxazole prophylaxis. This was thought to be a concrete
and feasible goal that would benefit large numbers of PLHA
relatively quickly and would counter a feeling of hopelessness
among them. 
ASSESSING COVERAGE OF
CO-TRIMOXAZOLE PROPHYLAXIS
MSF's home-based care programme in Bangkok demonstrat-
ed that inadequate knowledge of and access to the prophylax-
is and treatment of OIs were major causes of death among
PLHA. In order to assess the situation in other areas of
Thailand, MSF and partners carried out two surveys of PLHA
activists early in 2000. It emerged that of the people with
medical indications for co-trimoxazole prophylaxis fewer than
half were receiving it. A common reason for this was that peo-
ple believed AIDS to be untreatable (Box 3). 
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Box 2:Key community-based organiza-
tions and NGOs working on treatment
advocacy and treatment education
in Thailand
The Thai Network for People Living With HIV/AIDS (TNP+)
was formed in 1998 in order to coordinate the activities of
PLHA groups,which were isolated and lacked the ability to
push for change.Before 1998,PLHA had not been active on
health care issues.
The AIDS Access Foundation (AAF), a Thai NGO established
in 1991,focuses on social and cultural aspects of HIV/AIDS.
Through social campaigns and work with the media, this
body advocates for policies aimed at reducing the stigma
associated with HIV/AIDS.It also has extensive experience
in counselling and training.
Médecins sans Frontières (MSF) began working on
HIV/AIDS in Thailand in 1994,lending technical support to
local NGOs and providing home-based care for PLHA in
Bangkok.Pilot programmes supporting care and treat-
ment for PLHA in district hospitals began in 1997 and
ART was introduced in three hospitals in 2000.
A rally to lobby for access to treatmentTHE CO-TRIMOXAZOLE PROPHYLAXIS
CAMPAIGN
A project was launched to increase access to the prophylaxis
and treatment of OIs, focusing on increased awareness of the
use of co-trimoxazole for the prophylaxis of PCP. It was essen-
tial that PLHA should participate actively in their own treat-
ment and care if they were to develop the knowledge and
understanding necessary to believe that AIDS could be treat-
ed. The caring role of PLHA was therefore developed within
the public health care system (Fig. 2). Seven full-time NGO
staff supported the project, which was coordinated by seven
PLHA from TNP+. 
Perspectives and practice in antiretroviral treatment
INVOLVEMENT OF PEOPLE LIVING WITH HIV/AIDS3
Box 3:Lack of access to prophylaxis and treatment for OIs
MSF programme in Bangkok
◗ Of 501 adults with AIDS or symptomatic HIV infection enrolled in the MSF home-based care programme
up to mid-2000,302 (60%) were not receiving co-trimoxazole prophylaxis at the time of enrolment.
◗ Of 229 PLHA with recently diagnosed TB,137 (60%) had discontinued treatment before completion.
◗ Of 68 PLHA with previously diagnosed cryptococcal meningitis,59 (87%) were not receiving secondary
prophylaxis with fluconazole as recommended in MOPH guidelines.
Nationwide
MSF and TNP+ carried out two surveys to assess the situation in other areas of Thailand.
◗ The first was conducted in March 2000 among 170 PLHA from all parts of Thailand who were attending
a national TNP+ conference.A questionnaire was distributed to determine how many people with
symptomatic HIV infection were receiving co-trimoxazole prophylaxis.Of the 134 who completed the
questionnaire,81 had reported a symptomatic infection but only 40 of these were receiving the prophylaxis.
Of those not receiving co-trimoxazole prophylaxis,32 (78%) had not heard of it and 17 (41%) did not believe 
that AIDS-related conditions could be treated.
◗ In May 2000,similar results were obtained in a second survey conducted during an NGO forum in northern 
Thailand.Of 66 PLHA examined at an MSF mobile clinic,63 had symptomatic infection but only 29 (46%) 
were receiving co-trimoxazole prophylaxis.Two of six PLHA with a recent diagnosis of TB had discontinued 
treatment before completion because they felt better.Four of six PLHA with previously diagnosed
meningitis were not receiving secondary prophylaxis.
These surveys,showing co-trimoxazole coverage of under 50%,were conducted among relatively knowledge-
able PLHA attending conferences.It was thought that coverage would be even lower among the general
population of less knowledgeable PLHA.
Fig.1:The strategy of the Co-
trimoxazole Prophylaxis Campaign
PLHA develop
knowledge and
understanding
PLHA can access
prophylaxis and
treatment of OI
PLHA
participate
actively in
care and
treatment
PLHA
believe
that "AIDS
can be
treated"
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The following objectives were laid down for the period from
November 2000 to October 2002.
1. Members of PLHA groups participating in the project 
would have information on the prophylaxis, care and 
treatment of OIs.
2. All members of participating groups who had
symptomatic infection would be taking co-trimoxazole 
prophylaxis by October 2002. 
3. All members of participating groups who developed
TB would complete the correct treatment in accordance 
with MOPH guidelines.
4. All members of participating groups who developed  
meningitis would receive secondary prophylaxis with
fluconazole.
5. PLHA participating in the project would be able
to recommend the correct treatment for common
symptoms and OIs.
6. Coordination would occur between the public health
system, NGOs and PLHA on care and treatment.
157 interested PLHA groups were indentified, each having at
least two core members who could dedicate time to work on
the project. The core members' main responsibility was to
ensure that all other members with AIDS or symptomatic
infection in their group were receiving co-trimoxazole
prophylaxis by October 2002.
Core members were made responsible for:
(1) screening other members of their group for signs and 
symptoms of immune deficiency,
1 and referring them
to hospital if they were not receiving co-trimoxazole 
prophylaxis; 
(2) providing first aid for PLHA with common symptoms 
such as acute diarrhoea, fever and rash;
(3) referring PLHA to hospital if they had symptoms of OIs,
such as chronic cough, chronic fever, chronic diarrhoea 
and headache.
The initial training programme
The project began with the training of PLHA core members
so that they could fulfil their tasks of screening, basic treat-
ment of OIs and referral. Eight training courses were held
across the country. On average, 34 core members from 20
groups participated in each session. An outline of the work-
shops is given in Box 4.
1 The signs and symptoms of immune deficiency were those listed in the MOPH guidelines for the prevention of PCP, including a
list of clinical conditions that many PLHA were already familiar with: pruritic papular eruption, oral candidiasis, herpes simplex,
herpes zoster, chronic diarrhoea, TB, Cryptococcal meningitis and others. 
Box 4:Outline of workshops on basic
health care and knowledge of OIs in
people living with HIV/AIDS
Objectives
1. Participants should be able to provide care at home for
PLHA with common symptoms and some common OIs.
2. Participants should know which symptoms have to be 
referred to hospital.
3. Participants should understand the natural history
of HIV infection and the relationship between the CD4
count, the level of immunity and the occurrence of OIs.
4. Participants should be able to screen themselves and 
other PLHA for indications to begin co-trimoxazole 
prophylaxis.
5. Participants should understand the need for
continuous co-trimoxazole prophylaxis,for completing 
TB treatment and for continuous secondary prophylaxis
with fluconazole in cases of meningitis.
6. During and after the training,necessary support
should be given to participants who become newly 
aware that they have immune suppression.
Confidentiality should be maintained.
Basic information on ART was added to the training
in 2002.
Objectives
1. Participants should be able to help PLHA to make 
informed decisions on whether and when to start ART.
2.Participants should understand the importance
of good adherence,should know about common
side-effects and should understand that OIs can
continue to occur until immunity has improved.
Training approach: participatory;case studies;sharing of
experience.
Duration of training: three days.
Adapted from the curriculum developed by AAF,MSF and
the ASEAN Institute of Health Development of Mahidol
University,Bangkok,1999.INVOLVEMENT OF PEOPLE LIVING WITH HIV/AIDS 5
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An expected outcome of the training was that core PLHA
members would learn to recognize symptomatic HIV infec-
tion and would therefore know when to refer their friends to
a doctor for the commencement of co-trimoxazole prophy-
laxis. The outcome was assessed in the following way: before
each training course, participants volunteered to be screened
by an MSF nurse for signs of symptomatic HIV infection. On
the last day of each training session the participants intervie-
wed each other and carried out a simple history-taking and a
physical examination.
Of the 195 PLHA screened in this way, 122 were diagnosed
as having symptomatic HIV infection by MSF nurses while
131, including all those diagnosed by nurses, were diagnosed
as having symptomatic HIV infection by PLHA. The PLHA
core members overdiagnosed symptomatic HIV infection in
three cases of skin disease that was not HIV-related and in
three cases of asthma. However, they discovered two cases of
recurrent herpes simplex genitalis, about which their friends
had not informed the MSF nurses. 
Core PLHA members who had gained experience in screening
their peers and wanted to develop a role as peer educators were
offered places on a course for the training of trainers, and
eventually188 were trained from all regions of Thailand. In
2002 these PLHA trainers conducted a total of 66 three-day
workshops on OIs and ARV treatment, each attended by
20-30 participants (the training sessions were monitored by
MSF or AAF). 
ADDITIONAL HEALTH AWARENESS ACTIVITIES
In March 2001, MOPH announced that drugs for the pre-
vention and treatment of OIs would be covered by the state
health insurance scheme. MSF and AAF subsequently
conducted 11 workshops on OI prevention and treatment for
290 health care staff and facilitated three seminars in provin-
cial health offices with a view to raising awareness among heal-
th planners. 
Despite the wide acceptance in Thailand of the role of PLHA
in community education and the provision of mutual sup-
port, it was sometimes necessary to justify their new role  as
partners in care provision to hospitals. Advocacy was provided
by MSF and AAF during discussions with hospital staff. 
MSF and AAF also negotiated with hospital pharmacists to
increase stocks of  co-trimoxazole, assisted PLHA to gain
access to TB control programmes, and informed health
service management about the availability of  generic fluco-
nazole at reduced cost. Fluconazole ceased being a monopoly
product in Thailand in 1998. The price of one 200-mg cap-
sule of fluconazole fell from more than US$ 10.00 in 1998 to
$0.30 in 2001 but many hospitals and provincial health
offices were unaware of this.
The following documents were produced and distributed in
order to inform PLHA about treatment.
◗ 4000 bookmarks for distribution at meetings,
summarizing the natural history of HIV infection
and raising awareness of the need for co-trimoxazole 
prophylaxis. (Fig. 2 shows an English language version.)
Fig.2:Bookmark summarizing the natural history of HIV infection and raising
awareness of the need for co-trimoxazole prophylaxis
(Disease acronyms are:
CRYPTO=cryptococcal meningitis,
TB=tuberculosis,
PCP= Pneumocystis carinii pneumonia,
MAC= Mycobacterium avium,
TOXO= toxoplasmosis,
CMV= cytomegalovirus,
OC= oral candidiasis,
OHL= oral hairy leukoplakia,
PPE= pruritic papular eruption)
Both sides are shown.
The Thai version includes
contact phone numbers
for TNP+,MSF and AAF.◗ 20 000 posters for display in hospitals and PLHA
meeting rooms, giving information about
the prophylaxis and treatment of PCP, TB
and meningitis.
◗ 60 000 copies of a booklet entitled Know that AIDS 
can be treated (Fig. 3), based on MOPH guidelines
for the prophylaxis and treatment of OIs. All PLHA 
group members received copies.
◗ 3000 cards illustrating medicines commonly available in
Thailand for the prophylaxis and treatment of OIs, to 
be used by PLHA core members as a practical tool.
At the end of 2001 there was a significant increase in invest-
ment in the production of generic ARV drugs by the Thai
Government Pharmaceutical Organization. ART became
cheaper and access was possible for increased numbers of
PLHA. Information on ART was therefore included in the
training of PLHA and health care staff during the second
year of the campaign (Box 4) and a booklet entitled Know
AIDS together, treat AIDS together, giving basic information
on ART, was produced and distributed to all PLHA groups
in Thailand (Fig. 4).
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Fig.3:Front cover of the booklet:Know
that AIDS can be treated and an excerpt
explaining the concept of 'taking care 
of yourself'  (English translation)
'Taking care of yourself' means:
◗ you know how to take care of
your own health;
◗ you can access correct informa-
tion about your sickness and its
treatment;
◗ you do not diagnose and treat your sickness
by yourself but you can understand,assess
and manage your own health at a basic level;
◗ you take an active part in treatment
decisions along with your doctor or nurse;
◗ you understand your right to receive
treatment and correct information.
Fig.4:Front cover of the booklet Know
AIDS together,treat AIDS together and
an excerpt explaining the need for good
adherence (English translation)
Effective medical treatment
requires self-discipline:
ART requires precise self-disci-
pline.You need to take medicine
regularly and on time. Taking
each dose on time helps to main-
tain the level of medicine in the
blood,leading to a good treatment outcome
and reducing the chance of developing drug
resistance.A clear understanding of why you
need to take ART according to a regular sched-
ule is very important.An outline of campaign activities is presented in Box 5.
EVALUATION 
Impact on coverage of prophylaxis and
treatment of OIs 
After two years of the campaign, a survey was conducted on
the coverage of  co-trimoxazole prophylaxis, the treatment of
TB and secondary prophylaxis for  meningitis among PLHA.
Data were collected by means of questionnaires and random
sampling. Eighty of the 157 participating PLHA groups were
selected. In each group, data were obtained from one PLHA
core member who had received direct training through the
project and from six other members. The total sample size was
556 (76 core members  and 480 other members; four core
members were unavailable at the time of the survey).
Questionnaires were distributed at PLHA group meetings
during November and December 2002. 
Among the core group members, 55% (42) had symptomatic
HIV and 88% of these (37) were receiving co-trimoxazole
prophylaxis. The proportions were similar among the other
members of the groups: 65% (312) had symptomatic HIV
and 85% (266) of these were receiving co-trimoxazole pro-
phylaxis. Of those not receiving co-trimoxazole the main rea-
son cited was that their doctors did not prescribe it. 
Of the PLHA surveyed, 89 had been diagnosed with TB in
the preceding year (21 core members and 68 others). All the
core members and 54 other PLHA (84%) with a TB diagno-
sis had completed six months of TB treatment or, if they were
still undergoing treatment, knew that it should last for six
months.
Fourteen core members and 45 other PLHA had a previous
diagnosis of  meningitis. All core members were taking fluco-
nazole secondary prophylaxis, while 36 other members (81%)
were taking secondary prophylaxis.
These results indicate a significant increase in coverage of cor-
rect therapeutic interventions for the three OIs, from less than
50% before the project began to above 80%.  Fig. 5 shows
only a general trend because the percentages given for PLHA
receiving correct treatment for TB and secondary prophylaxis
of  meningitis during 2000 are based on small numbers.
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Box 5:Summary of activities of the
Co-trimoxazole Prophylaxis Campaign
(November 2000 to October 2002)
◗ Recruitment of PLHA groups interested in becoming 
pilot groups for the project.
◗ Expanding the knowledge of PLHA,NGOs and public 
hospital staff through the development and
implementation of training on the care and
treatment of OIs.
◗ Evaluation of training sessions,and further training
and ongoing support as required.
◗ Linking with hospitals,including the organization
of workshops for health service personnel.
◗ Organization of seminars at provincial health offices 
with involvement of health care planners.
◗ Production and distribution to PLHA of documents
giving information on OIs.
◗ Development of training of trainers curriculum
for PLHA on the care and treatment of OIs.
◗ Recruitment of PLHA trainers and provision of training 
of trainers courses.(Trainers provide training to other 
members of PLHA groups in their areas.)
◗ Introduction of basic information about ART during
the second year.
◗ Monitoring and supporting the work of the PLHA
pilot groups though the TNP+ network.8 INVOLVEMENT OF PEOPLE LIVING WITH HIV/AIDS
Fig.5:Coverage of OI prophylaxis and treatment before and after the Campaign
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Impact on the PLHA network
On completion of the campaign the participating organiza-
tions observed that communication and teamwork between
different groups had improved and that PLHA had become
much more motivated to take care of their own health and
that of their friends. Many pilot groups had developed a
clearer understanding of health issues and of their role. Many
felt that this had led to an overall strengthening of the PLHA
network.
Inadequate supervision and lack of ongoing support were
identified as the main weaknesses of the campaign, attribu-
table to a shortage of personnel with adequate skills and to
insufficient funds. There were frequent changes of core
members after training, most often because they needed to
find full-time work in order to support themselves and their
families. This necessitated the recruitment of new core mem-
bers and more work for the training teams. The absence of a
uniform system for recording data made it difficult to report
on the campaign.
The Co-trimoxazole Prophylaxis Campaign showed that,
with appropriate training and support, PLHA could develop
a role as partners in the provision of health care, supporting
access to the prophylaxis and treatment of common OIs. 
PLHA received better health care and their confidence increa-
sed. The value of this role to health care providers is evident
in one of the comments in Box 1.
Using the experience of this campaign and the stronger net-
working that emerged, the participating organizations are hel-
ping to prepare PLHA to support access and adherence to
treatment within the national ART programme of MOPH. A
regional Co-trimoxazole Prophylaxis Campaign, targeting
community-based organizations in Cambodia, Laos,
Myanmar, and Viet Nam was launched in July 2004 at the
Fifteenth International AIDS Conference in Bangkok.
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Antiretroviral treatment as part of
comprehensive and continuous care:
developing the role of people living with
HIV/AIDS as partners in care provision
In April 2002, MOPH expanded access to ART and invited
all interested hospitals to apply for treatment slots. In each
participating hospital a Centre of Comprehensive and
Continuous Care (CCC) was to be established in which ART
would be provided by a multidisciplinary team, viz. doctor,
nurses, pharmacist and laboratory technician.
In July 2002, TNP+, MSF and AAF decided to utilize the
experience of the Co-trimoxazole Prophylaxis Campaign in
order to develop the role of PLHA as partners in the provision
of comprehensive and continuous care. The CCC Centres
were viewed as a tool not only enabling PLHA to access treat-
ment but also allowing PLHA core members to provide treat-
ment support. Some services in the CCC Centres, such as psy-
chological and social support provided by means of individual
or small-group counselling and home visits (Fig. 6), were not
new, having previously been available through peer support
groups, but there was now an additional goal of supporting
access to treatment. 
As well as having knowledge of OIs and ART, PLHA core
members had to develop skills in adherence support. ART
projects, including a TNP+ Buyers' Club (8) and pilot pro-
jects in district hospitals supported by MSF, had led to an
understanding of the importance of certain key steps in the
ART information and counselling process and of ongoing
adherence support (Box 6). Core PLHA members needed
training on counselling skills. In order to plan their work and
manage a case-load of clients, each with her or his problems,
they had to understand the concept of the care continuum.
Appropriate workshops were designed and implementation
began.
The following criteria were used to select PLHA groups with
the capacity to participate actively in CCC centers:
◗ The groups had to have at least two core members
committed to working on a regular basis.
◗ Before starting work, each core PLHA member was 
required to have attended three training workshops
on OIs and ART, counselling and the care continuum. 
◗ There had to be a working link between each PLHA 
group and a hospital. A work plan was required to have 
been drawn up and to have been approved by the hospital
director. There had to be a forum for case discussion, 
the sharing of information and problem-solving. 
◗ A budget had to be available for project activities, 
together with transparent financial management
and reporting.Box 6:Key points in ensuring adherence to ART
A:THE PRE-ENROLMENT INFORMATION AND COUNSELLING PROCESS
The process of offering information,counselling and adherence support must be carried out by staff (counsellors and/or
PLHA) who understand the problems in the lives of PLHA. There are 3 steps in this process.In some cases all 3 steps may
be carried out during one session.In other cases,several sessions may be needed.
Step 1 – Giving information
Clients are given basic information enabling them to understand the need for a high level of commitment to treatment
and adherence.Information can be provided to a group of PLHA clients if the facilitator has some understanding of
group dynamics and is able to stimulate group discussion.
Step 2 – Counselling – in one or more individual sessions
During this step, the counsellor must do the following:
◗ Help the client explore his/her feelings.Many clients will be preoccupied with problems related to family,job,
relationships etc.,and cannot focus on strict adherence until they have released negative feelings about
these problems.
◗ Help the client explore his/her options.Many will have no private place to store their medicines and will not be able
to take them in secret.Not wanting others to know their HIV status is by far the commonest reason we come across 
for poor adherence.The client needs to be realistic about who needs to know their HIV status and how to tell them.
Step 3 – Solving practical problems and creating a treatment plan 
Where will the ARV drugs be stored? At what time will it be taken? Who will remind the client to take it if he or she for-
gets? What will the client do if her or his normal routine is interrupted? A time should be arranged to meet or telephone
the client within a few days in order to discuss any problems.
B:FOLLOW-UP AND ADHERENCE SUPPORT
People's lives and circumstances change.PLHA may get new jobs,meet new friends and form new relationships.These
are the commonest reasons for the discontinuation of treatment.Ongoing nonjudgemental support is necessary in
order to ensure that adherence to ART continues when such changes occur.Support can be provided by telephone,in
one-to-one counselling sessions,group meetings and during home visits.
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The funding was requested from the Global Fund to Fight
AIDS, TB and Malaria in 2002 and  received a year later. This
delay held back the implementation of many activities. By
May 2004, however, PLHA core members were participating
in care and support for 7086 PLHA (adults and children)
receiving ART in 105 public hospitals (19 at provincial level
and 86 at district level) and in one women's prison. This
represented 31% of the PLHA taking ART in 12% of the hos-
pitals in the government programme. The number of PLHA
followed in each CCC Centre ranged from six to 347 (median
= 42). Fig. 7 shows the distribution of these Centres. Most are
in the north and north-east of the country, where the PLHA
movement has traditionally been strongest and where the
regional public health offices have been most open to PLHA
participation.   Fig.6:CCC Centers with PLHA participation in provision  of health care in Thailand
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CONCLUSIONS 
The role of PLHA in providing peer support has been widely
accepted and encouraged in Thailand for many years. Their
role as health care providers in coordination with professional
health workers gained acceptance in many hospitals and by
many health planners during the course of this work. 
Knowledge and understanding of the importance of co-tri-
moxazole prophylaxis has been successfully used as a tool for
changing attitudes to AIDS. The increased involvement of
PLHA as co-providers in care has also contributed to a posi-
tive change in the attitude of health care staff. A few years ago,
health care for AIDS was mainly provided from specialist
centres; many staff at district level were unable to provide even
basic care. Today, nearly every hospital in Thailand sees it as
its responsibility to provide care for PLHA. Furthermore,
there are now greater opportunities for PLHA to work in
health care provision, although this role is not yet accepted
throughout the country. 
Thailand has a unique network of NGOs and PLHA groups
working on treatment issues. By influencing the design of the
MOPH programme and involving themselves in its imple-
mentation, PLHA are ensuring that a key element of the
"3 by 5" strategy is in place. As the comments by key stake-
holders at the beginning of this case study show, participation
by PLHA as partners in care provision has important spin-offs
for both health care providers and PLHA themselves.
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